Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sean D Adrean, Siyang Chaili, Ash Pirouz & Scott Grant. (2020) Central Serous Chorioretinopathy in Elderly Patients Mimicking Occult Neovascular Age-Related Macular Degeneration. Clinical Ophthalmology 14, pages 4073-4078.
Read now
Read now
Articles from other publishers (9)
Sónia Torres-Costa, Susana Penas, Ana Rita Cerqueira, Elisete Brandão, Ângela Carneiro, Amândio Rocha-Sousa & Fernando Falcão-Reis. (2021) Long term outer retinal changes in central serous chorioretinopathy submitted to half-dose photodynamic therapy. Photodiagnosis and Photodynamic Therapy 34, pages 102235.
Crossref
Crossref
Stefano Da Pozzo, Pierluigi Iacono, Alessandro Arrigo & Maurizio Battaglia Parodi. (2021) The Role of Imaging in Planning Treatment for Central Serous Chorioretinopathy. Pharmaceuticals 14:2, pages 105.
Crossref
Crossref
Pierluigi Iacono, Stefano Da Pozzo, Monica Varano & Mariacristina Parravano. (2020) Photodynamic Therapy with Verteporfin for Chronic Central Serous Chorioretinopathy: A Review of Data and Efficacy. Pharmaceuticals 13:11, pages 349.
Crossref
Crossref
Takehito Iwase, Hirotaka Yokouchi, Masayasu Kitahashi, Mariko Kubota-Taniai, Takayuki Baba & Shuichi Yamamoto. (2020) Long-Term Effects of Half-Time Photodynamic Therapy on Retinal Sensitivity in Eyes with Chronic Central Serous Chorioretinopathy. BioMed Research International 2020, pages 1-10.
Crossref
Crossref
Dong Yoon Kim, Jong Young Lee, Eun Kyoung Lee & Jin Young Kim. (2020) COMPARISON OF VISUAL/ANATOMICAL OUTCOMES AND RECURRENCE RATE BETWEEN ORAL SPIRONOLACTONE AND PHOTODYNAMIC THERAPY FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY. Retina 40:6, pages 1191-1199.
Crossref
Crossref
Thomas J. van Rijssen, Sumit Randhir Singh, Elon H. C. van Dijk, Mohammed A. Rasheed, Kiran Kumar Vupparaboina, Camiel J. F. Boon & Jay Chhablani. (2020) Prospective evaluation of changes in choroidal vascularity index after half-dose photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 258:6, pages 1191-1197.
Crossref
Crossref
Thomas J. van Rijssen, Elon H.C. van Dijk, Suzanne Yzer, Kyoko Ohno-Matsui, Jan E.E. Keunen, Reinier O. Schlingemann, Sobha Sivaprasad, Giuseppe Querques, Susan M. Downes, Sascha Fauser, Carel B. Hoyng, Felice Cardillo Piccolino, Jay K. Chhablani, Timothy Y.Y. Lai, Andrew J. Lotery, Michael Larsen, Frank G. Holz, K. Bailey Freund, Lawrence A. Yannuzzi & Camiel J.F. Boon. (2019) Central serous chorioretinopathy: Towards an evidence-based treatment guideline. Progress in Retinal and Eye Research 73, pages 100770.
Crossref
Crossref
Thomas J. van Rijssen, Danial Mohabati, Greet Dijkman, Thomas Theelen, Eiko K. de Jong, Elon H. C. van Dijk & Camiel J. F. Boon. (2018) Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy. PLOS ONE 13:8, pages e0202549.
Crossref
Crossref
Daren Hanumunthadu, AnnaC S Tan, SumitRandhir Singh, NirojKumar Sahu & Jay Chhablani. (2018) Management of chronic central serous chorioretinopathy. Indian Journal of Ophthalmology 66:12, pages 1704.
Crossref
Crossref